All Stories

  1. Central vs. Peripheral Access Samplings in Patients on Hemodialysis Induce Variations in Parathyroid Hormone Levels
  2. Role of Antitroponin Antibodies and Macrotroponin in the Clinical Interpretation of Cardiac Troponin
  3. Abstract 5169: Circulating levels of ANGPTL3, PCSK9, apoCIII and lipoprotein (a) in high-grade serous ovarian cancer
  4. Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary
  5. Levels of ANGPTL3 and characterization of other circulating cholesterol-related factors in high-grade serous ovarian cancers.
  6. The Progression of Interstitial Fibrosis and Tubular Atrophy at 6 Months Is an Independent Predictor of Poor Graft Outcomes in Kidney Transplant Recipients
  7. Current use of bone turnover markers in the management of osteoporosis
  8. Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian Carcinoma
  9. Impact of the 2016 Canadian Lipid Guidelines on Daily Practice at a Community Hospital
  10. POS-443 AN UNUSUAL TREATMENT FOR 1,25 DIHYDROXY VITAMIN D3 - 24 HYDROXYLASE DEFICIENCY INDUCED HYPERCALCIURIA - CASE REPORT
  11. 335 Low BRCA 1/2 germline mutation rate in a french canadian population
  12. Impact of the Martin/Hopkins modified equation for estimating LDL-C on lipid target attainment in a high risk patient population
  13. Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
  14. Variability of High-Sensitivity Troponin T Concentrations in Emergency Settings
  15. Relationships Between Serum IL-6, Tobacco Consumption, and the Occurrence of Second Primary Cancers in Head and Neck Cancer Patients
  16. Comparison of fasting and non-fasting lipid profiles in a large cohort of patients presenting at a community hospital
  17. Serum Parathyroid Hormone and 25-Hydroxyvitamin D Concentrations Before and After Biliopancreatic Diversion
  18. Prediction and validation of the duration of hemodialysis sessions for the treatment of acute ethylene glycol poisoning
  19. The Effect of Triglyceride Concentration on Attainment of Lipid Targets in Patients with Diabetes
  20. Performance of preoperative plasma HE4 and CA-125 levels in predicting ovarian cancer mortality in women with epithelial ovarian cancer (EOC).
  21. Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1,041 melanoma patients
  22. The Case | An unusual case of intoxication
  23. Prediction and validation of hemodialysis duration in acute methanol poisoning
  24. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas
  25. FP475PREDICTION AND VALIDATION OF HEMODIALYSIS DURATION IN INTENTIONAL METHANOL POISONING
  26. The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: a longitudinal study
  27. Active Vitamin D and Accelerated Progression of Aortic Stiffness in Hemodialysis Patients: A Longitudinal Observational Study
  28. Human epididymis protein 4 (HE4) and ovarian cancer prognosis
  29. The Impact of Germline Genetic Variations in Hydroxysteroid (17-Beta) Dehydrogenases on Prostate Cancer Outcomes After Prostatectomy
  30. SRD5A Polymorphisms and Biochemical Failure After Radical Prostatectomy
  31. Deletions of the Androgen-MetabolizingUGT2BGenes Have an Effect on Circulating Steroid Levels and Biochemical Recurrence after Radical Prostatectomy in Localized Prostate Cancer
  32. primary aldosteronism screening test
  33. 2288 PROGNOSTIC IMPACT OF INHERITED GENETIC VARIATIONS IN SRD5A AND ANDROGEN INACTIVATING UGT2B GENES IN PROSTATE CANCER AFTER PROSTATECTOMY
  34. Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis
  35. Dietary vitamin D intake and serum 25‐hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients
  36. 2122 COPY NUMBER VARIATION OF SEX-STEROID METABOLIZING GENES AS BIOMARKERS OF PROSTATE CANCER RECURRENCE AFTER PROSTATECTOMY: LOOKING AT THE END OF THE ANDROGENIC SIGNAL
  37. Serum Prognostic Markers in Head and Neck Cancer
  38. Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform
  39. Bone turnover markers in the management of postmenopausal osteoporosis
  40. Impact of age on glomerular filtration estimates
  41. Morning Plasma Aldosterone Predicts the Subtype of Primary Aldosteronism Independant of Sodium Intake
  42. A Prospective Study of the Insulin-Like Growth Factor Axis in Relation with Prostate Cancer in the SU.VI.MAX Trial
  43. Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock
  44. Nonfasting Non-High-Density Lipoprotein Cholesterol Is Adequate for Lipid Management in Hemodialysis Patients
  45. Problems with the estimation of urine protein by automated assays
  46. Insulin-Like Growth Factor Binding Protein 2: An Androgen-Dependent Predictor of Prostate Cancer Survival
  47. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial
  48. Active renin concentration and the aldosterone/renin ratio in screening primary aldosteronism
  49. Monoclonal Paraprotein May Interfere with the Roche Direct HDL-C Plus Assay
  50. Functional tests for primary aldosteronism: Value of captopril suppression
  51. Effects of Electric and Magnetic Fields from High-power Lines on Female Urinary Excretion of 6-Sulfatoxymelatonin
  52. Captopril Suppression Versus Salt Loading in Confirming Primary Aldosteronism
  53. HDL Cholesterol and TaqIB Cholesteryl Ester Transfer Protein Gene Polymorphism in Renal Transplant Recipients
  54. Effect of Terminal Renal Failure on the Ratio of Free to Total Prostate-Specific Antigen
  55. 2.P.244 Relatinship between plasma endothelin-1, HDL-C and systolic blood pressure in renal transplant recipients
  56. DRE-PSA Data Revisited: PSA Sampling Should Precede DREs
  57. A new rapid immunoinhibition pancreatic amylase assay: Diagnostic value for pancreatitis
  58. Visceral perception in health and functional dyspepsia
  59. An Approach to the Use of Clinical Limits for Quality Control
  60. Adult Celiac Sprue
  61. The relationship between serum fructosamine and albumin
  62. Performance of three new blood-glucose reflectometers evaluated by nursing and laboratory staffs.
  63. Adaptation d'une trousse commerciale de mesure de la myoglobine sérique pour la recherche de la myoglobine urinaire
  64. Evaluation of the average of patients: application to endocrine assays
  65. Optimisation mathématique de la mesure du fluorure sérique par addition connue avec électrode sélective
  66. Performance of glucose measurements with reflectometers outside the laboratory in relation to the frequence of utilization
  67. HLA-A B and DR Matching in Corneal Transplantation
  68. The influences of the between‐ and within‐run components of variation on themean rule
  69. Diagnostic value of sequential readings with the Minolta transcutaneous bilirubinometer in normal and low-birthweight infants.
  70. Performance of the Hitachi 705 evaluated.
  71. Potential usefulness of serum prealbumin in total parenteral nutrition.
  72. Evaluation of the automatic analyser hitachi 705